While traditional cardiovascular risk factors remain essential for risk assessment, our results highlight the added value of composite indices such as lnPIV and AIP in refining the prediction of CCS, particularly among NAFLD patients. The gene discussed is AIP; the disease is metabolic dysfunction-associated steatotic liver disease.